COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
31/08/2026
Company announcement No. 44 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, August 31, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Kegel Care Launches Personalized Pelvic Floor Training App for Women
31/08/2026
New Kegel Care App Turns a Short Quiz Into a Guided Kegel Plan NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Kegel Care has launched a pelvic health and wellness app built around personalized Kegel exercises for women. [...]
New genomics collaboration to enable First Nations sovereignty over salmon data
31/08/2026
VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- A new multi-year, multi-partner collaboration aims to empower First Nations communities in British Columbia with salmon genetic analysis tools, technology, [...]
Coherus to Participate in Upcoming Investor Conferences
31/08/2026
REDWOOD CITY, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS), today announced that the company will be participating in upcoming investor conferences: Baird 2026 Global Healthcare [...]
ProSomnus Prevails in Intellectual Property Enforcement Action
31/08/2026
Federal Court Awards Damages, Fees and Costs Following ProSomnus Intellectual Property Enforcement Action SAN FRANCISCO, Aug. 31, 2026 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (“ProSomnus”), the pioneer and [...]
Persevere Therapeutics Announces Appointment of James Barlow to Board of Directors
31/08/2026
Chesterbrook, PA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”), a clinical-stage oncology company developing misetionamide — a first-in-class inhibitor of MYC, historically viewed as [...]
SEMCAP Beauty & Wellness Leads Funding Round For Healf
31/08/2026
SEMCAP Beauty & Wellness leads investment in Healf, the personalized wellbeing platform helping consumers make more confident decisions about their health. Healf combines expert curation, diagnostics, wearable [...]
AIM ImmunoTech Secures Broad U.S. Patent for Rintatolimod (Ampligen®) Used in Combination with Pembrolizumab (Keytruda®), Expanding Oncology IP Protection for Ampligen Through 2039
31/08/2026
Patent covers synergistic use of Ampligen with pembrolizumab across cancer indications, including pancreatic, ovarian, colorectal, breast, lung and other cancers, reinforcing the potential breadth and long-term value of [...]
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
31/08/2026
Berkeley, CA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA) (the “Company”) announced that it has received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market [...]
Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
31/08/2026
New NIH award will provide approximately $908,000 in year-long support of preclinical development, with potential for an additional future-year grant of approximately $1.3 million DARE-PTB2 is an early-stage, [...]
OneMedNet’s iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company
31/08/2026
Customer selects OneMedNet for the full-fidelity studies and regulatory decision-grade quality required to develop AI models that accelerate drug development MINNEAPOLIS, Aug. 31, 2026 (GLOBE NEWSWIRE) -- OneMedNet [...]
Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD
31/08/2026
Chloe Kim is partnering with Supernus to highlight the importance of recognizing ADHD in adults and help empower individuals to work with their doctors to develop a tailored treatment plan. While ADHD is often [...]
Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure
31/08/2026
Findings presented at ESC Congress 2026 and simultaneously published in JACC: Heart Failure THE WOODLANDS, Texas, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced results [...]
Allogene Therapeutics Announces Participation in September Investor Conference
31/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for [...]
Arch Biopartners Receives Central IRB Approval to Support U.S. Sites in Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial of LSALT Peptide
31/08/2026
TORONTO, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc . (TSX Venture: ARCH and OTCQB: ACHFF) today announced that it has received central Institutional Review Board (“IRB”) approval of the protocol and related [...]
Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
31/08/2026
Presentations Expand Understanding of Treatment Adherence, Long-Term Outcomes, Lipoprotein(a), Coagulation Biomarkers, and Potential Mechanisms of Eicosapentaenoic Acid (EPA) 2026 ESC/ European Renal Association (ERA) [...]
OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
31/08/2026
BOULDER, Colo., Aug. 31, 2026 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines, today announced that senior [...]
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
31/08/2026
BOSTON, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, [...]
Sofwave Announces Publication of Data from Randomized Controlled Study of its Pure Impact™ VIP Platform Utilizing PlyoPulse™ EMS Technology in Aesthetic Surgery Journal
31/08/2026
A prospective randomized controlled trial of an aesthetic EMS platform to assess objective functional performance reports improvements across four standardized tests SAN CLEMENTE, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE [...]

Pages